10-K: Elevance Health Reports Strong 2024 Results, Navigates Medicaid Redeterminations and Medicare Star Ratings Impact

Elevance Health showcases a resilient performance in 2024, marked by revenue growth and strategic acquisitions, while addressing challenges from Medicaid redeterminations and adjustments in Medicare Advantage Star Ratings.

Summary

• Elevance Health reported a 2.9% increase in operating revenue, reaching $175.2 billion for the year ended December 31, 2024.
• The company's medical membership stood at 45.7 million as of December 31, 2024, reflecting a decrease primarily due to Medicaid attrition.
• Net income for 2024 was $5.97 billion, a slight decrease compared to $5.99 billion in 2023.
• The company experienced growth in its commercial plans, including the Public Exchanges, as former Medicaid members sought alternative coverage options.
• Elevance Health is entering select service areas in Florida, Maryland, and Texas in 2025, using its Simply Healthcare and Wellpoint brands.
• The company expects a reduction to its 2026 operating revenue of approximately $183 million due to changes in Medicare Advantage Star Ratings.
• Elevance Health completed several strategic acquisitions in 2024, including Paragon Healthcare and CareBridge, to expand its Carelon services.
• The company sold its life and disability businesses to StanCorp Financial Group, Inc. in April 2024, resulting in a gain on sale of $201 million.
• The company is managing the impact of Medicaid eligibility redeterminations, which have led to a decline in Medicaid membership.
• The company is committed to a fair pay workplace and has been certified by the Fair Pay Workplace (FPW).

Sentiment

Score: 7

Explanation: The document presents a mixed sentiment. While there's revenue growth and strategic acquisitions, there are also challenges like Medicaid redeterminations and Medicare Star Ratings impact. The company is taking steps to mitigate these challenges, indicating a proactive approach.

Positives

• Operating revenue increased by 2.9% to $175.2 billion in 2024.
• The company is entering select service areas in Florida, Maryland, and Texas in 2025, using its Simply Healthcare and Wellpoint brands.
• The company completed several strategic acquisitions in 2024, including Paragon Healthcare and CareBridge.
• The company sold its life and disability businesses to StanCorp Financial Group, Inc. in April 2024, resulting in a gain on sale of $201 million.
• The company is committed to a fair pay workplace and has been certified by the Fair Pay Workplace (FPW).
• The company's 2024 Star Ratings, which are used for payment year 2025, reflect that 53% of our Medicare Advantage members are enrolled in plans rated at least 4.0 Stars or higher.

Negatives

• Medical membership decreased by 1.1 million, or 2.3%, during the year ended December 31, 2024.
• Net income for 2024 was $5.97 billion, a slight decrease compared to $5.99 billion in 2023.
• The company expects a reduction to its 2026 operating revenue of approximately $183 million due to changes in Medicare Advantage Star Ratings.
• Medicaid rates being inadequate to cover medical cost trends that were well in excess of historical averages due to Medicaid membership eligibility redeterminations.

Risks

• Failure to appropriately predict, price for and manage healthcare costs could decline profitability.
• A significant reduction in enrollment in health benefits programs, pharmacy services or diversified products and services could have an adverse effect.
• A cyber-attack or other privacy or data security incident could result in an unauthorized disclosure of sensitive or confidential information.
• There are various risks and conditions associated with participating in Medicare and Medicaid programs, including payment rates, processes and timelines that are determined by the government, compliance with government contract requirements and regulatory oversight.
• If we fail to develop and maintain satisfactory relationships with hospitals, physicians, pharmacy service providers and other healthcare providers, our business may be adversely affected.
• We are subject to significant government regulation, and changes or proposed changes in the regulation of our business by federal and state regulators may adversely affect our business.
• We face competition in many of our markets, and if we fail to adequately adapt to changes in our industry and develop and implement strategic growth opportunities, our ability to compete and grow may be adversely affected.
• We have built a significant portion of our current business through mergers and acquisitions, joint ventures, strategic alliances and investments, and although we expect to pursue such opportunities in the future, we are subject to risks resulting from such business combinations.
• We face intense competition to attract and retain associates. Further, managing key executive succession and retention is critical to our success.
• Restrictions on our ability to obtain funds from our regulated subsidiaries could limit our ability to repurchase shares, pay dividends and meet our obligations and materially adversely affect our business.
• We have substantial indebtedness outstanding and may incur additional indebtedness in the future, which could adversely affect our ability to pursue desirable business opportunities and to react to changes in the economy or our industry.
• A downgrade in our credit ratings could have an adverse effect on our business.
• The value of our intangible assets may become impaired.
• The value of our investments is influenced by varying economic and market conditions, and a decrease in value may result in a loss charged to income.
• The health benefits industry is subject to negative publicity, which could adversely affect our business.

Future Outlook

Elevance Health anticipates growth in its Public Exchange membership and is entering select service areas in Florida, Maryland, and Texas in 2025. The company expects a reduction to its 2026 operating revenue of approximately $183 million due to changes in Medicare Advantage Star Ratings but expects to mitigate the financial impact through various strategies.

Industry Context

The managed care industry is highly competitive, with participants competing on quality of service, price, access to provider networks, innovation, and brand recognition. The company believes its exclusive right to market products under the BCBS brand in its most significant markets provides it with greater brand recognition over competitive product offerings.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards in terms of financial performance or operational metrics.
• However, it mentions that the company strives to price its health benefit products and design its Medicare and Medicaid bids consistent with anticipated underlying medical trends, suggesting an awareness of industry benchmarks.
• The document also notes that the company's relationships with physicians, hospitals, and professionals are guided by local, regional, and national standards for network development, reimbursement, and contract methodologies.

Legal Proceedings

• The company is a defendant in multiple lawsuits that were initially filed in 2012 against the BCBSA and Blue Cross and/or Blue Shield licensees.
• The company is also involved in, or may in the future be party to, pending or threatened litigation incidental to the business we transact or arising out of our operations, including, but not limited to, breaches of security and violations of privacy requirements, shareholder actions, compliance with federal and state laws and regulations (including qui tam or whistleblower actions), or sales and acquisitions of businesses or assets.

Related Party Transactions

• The company has an equity investment in APC Passe, LLC, which offers Medicaid products in Arkansas.
• The company made an equity investment that resulted in its minority interest ownership of Liberty Dental. During the years ended December 31, 2024 and 2023, in the normal course of business, Liberty Dental provided administrative services to our Medicare Advantage members under a capitated arrangement amounting to $519 million and $426 million, respectively, reported in benefit expense.

Stakeholder Impact

• Shareholders: The company's performance impacts shareholder value, including stock price and dividends.
• Employees: The company's ability to attract and retain associates is critical to its success.
• Customers: The company's ability to provide cost-effective health benefits products and services is important to customers.
• Providers: The company's relationships with hospitals, physicians, and other healthcare providers are important for providing quality care to members.
• Members: The company seeks to understand our members' health-related social needs to create a healthcare system that synchronizes care delivery for physical, behavioral, social and pharmacy needs.

Next Steps

• The company will continue to evaluate the impact of the ACA as any further developments occur.
• The company will continue to enhance interactions with customers, providers, brokers, agents, employees and other stakeholders through digital technology and improvements to internal operations.
• The company expects to mitigate the financial impact to our 2026 operating gain and net income per share through various strategies such as contract diversification, operating expense efficiencies, capital deployment alternatives and network enhancements.

Key Dates

Keywords

Elevance Health, financial results, medical membership, operating revenue, net income, Medicaid, Medicare, Carelon, acquisitions, risk factors, healthcare, insurance